NC
RGEN icon

NZS Capital’s Repligen RGEN Stock Holding History

NZS Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.9M Buy
203,225
+4,422
+2% +$618K 0.8% 45
2025
Q4 		$32.6M Buy
198,803
+2,026
+1% +$317K 1% 41
2025
Q3 		$26.3M Buy
196,777
+51,483
+35% +$6.25M 0.81% 44
2025
Q2 		$18.1M Buy
145,294
+13,372
+10% +$1.7M 0.61% 49
2025
Q1 		$16.8M Sell
131,922
-1,772
-1% -$273K 0.76% 46
2024
Q4 		$19.2M Buy
133,694
+5,855
+5% +$840K 0.82% 44
2024
Q3 		$19M Buy
127,839
+3,617
+3% +$519K 0.74% 48
2024
Q2 		$15.7M Buy
124,222
+42,700
+52% +$6.69M 0.64% 48
2024
Q1 		$15M Sell
81,522
-954
-1% -$182K 0.62% 46
2023
Q4 		$14.8M Buy
82,476
+45,272
+122% +$7.05M 0.78% 43
2023
Q3 		$5.92M Buy
37,204
+8,672
+30% +$1.42M 0.32% 58
2023
Q2 		$4.04M Buy
+28,532
New +$4.57M 0.2% 63

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

NZS Capital's RGEN Position: Q1 2026 in Review

NZS Capital increased its Repligen (RGEN) stake by 2.2% in Q1 2026, buying an estimated $618K and bringing the position to 203,225 shares worth $23.9M. The position accounts for 0.8% of the portfolio, ranked #45.

NZS Capital first reported a position in RGEN in Q2 2023 and has held it in 12 quarters since. The position peaked at $32.6M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • NZS Capital held 203,225 shares of Repligen worth $23.9M as of Q1 2026.
  • NZS Capital bought 4,422 Repligen shares in Q1 2026, an estimated $618K.
  • Repligen made up 0.8% of NZS Capital's portfolio in Q1 2026, its #45 holding.
  • NZS Capital first reported a position in Repligen in Q2 2023 and has held it in 12 quarters since.
  • NZS Capital's Repligen position peaked at $32.6M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on NZS Capital's 13F filing for Q1 2026, filed 15 May 2026.